Lumosa Therapeutics Co., Ltd. (6535.TWO)
TWD 144.0
(-10.0%)
TWD 144.0
(-10.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 41.48 Million TWD | 30.15% |
| 2022 | 320.48 Million TWD | -27.19% |
| 2021 | 440.16 Million TWD | 24.09% |
| 2020 | 354.71 Million TWD | 39.22% |
| 2019 | 254.78 Million TWD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 82.09 Million TWD | -32.85% |
| 2024 Q2 | 78.11 Million TWD | -4.82% |
| 2023 Q2 | 119.68 Million TWD | 61.69% |
| 2023 Q4 | 122.25 Million TWD | 20.87% |
| 2023 FY | 417.1 Million TWD | 30.15% |
| 2023 Q1 | 74.02 Million TWD | 9.57% |
| 2023 Q3 | 101.14 Million TWD | -15.49% |
| 2022 Q3 | 81.74 Million TWD | 0.0% |
| 2022 FY | 320.48 Million TWD | -27.19% |
| 2022 Q4 | 67.55 Million TWD | -17.36% |
| 2021 FY | 440.16 Million TWD | 24.09% |
| 2020 FY | 354.71 Million TWD | 39.22% |
| 2019 FY | 254.78 Million TWD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 127.67 Million TWD | 67.509% |
| Level Biotechnology Inc. | 151.99 Million TWD | 72.709% |
| Sagittarius Life Science Corp | 135.85 Million TWD | 69.466% |
| NeoCore Technology Co., Ltd. | 75.85 Million TWD | 45.318% |
| TaiMed Biologics Inc. | 225.23 Million TWD | 81.583% |
| GlycoNex Incorporation | 995 Thousand TWD | -4068.945% |
| VBI | 32.55 Million TWD | -27.418% |
| GeneReach Biotechnology Corp. | 256.86 Million TWD | 83.851% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 194.18 Million TWD | 78.639% |
| Visgeneer Inc. | 67.48 Million TWD | 38.53% |
| Mycenax Biotech Inc. | -375.19 Million TWD | 111.056% |
| Sunmax Biotechnology Co., Ltd. | 510.09 Million TWD | 91.868% |
| G&E Herbal Biotechnology Co., Ltd. | 63.9 Million TWD | 35.088% |
| Medigen Vaccine Biologics Corporation | 1.44 Billion TWD | 97.127% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 29.35 Million TWD | -41.323% |
| Enimmune corporation | 220.1 Million TWD | 81.154% |
| TaiRx, Inc. | 217.13 Million TWD | 80.896% |
| CHO Pharma, Inc. | 268.99 Million TWD | 84.579% |
| EirGenix Inc. | 236.74 Million TWD | 82.478% |
| BioLASCO Taiwan Co., Ltd. | 104.35 Million TWD | 60.249% |
| Sunny Pharmtech Inc. | 357.62 Million TWD | 88.401% |
| Lin BioScience, Inc. | 1.09 Billion TWD | 96.218% |
| BioGend Therapeutics Co., Ltd. | 266.15 Million TWD | 84.415% |
| Feng Chi Biotech Corp. | 49.47 Million TWD | 16.151% |
| Bio Preventive Medicine Corp. | 1.08 Million TWD | -3730.194% |
| Lukas Biomedical Inc. | 177.45 Million TWD | 76.624% |
| RBC Bioscience Corporation | 58.35 Million TWD | 28.917% |
| BiOptic Inc. | 108.69 Million TWD | 61.836% |
| BRIM Biotechnology, Inc. | 90 Thousand TWD | -45990.0% |
| Shine-On BioMedical Co.,Ltd. | 69.35 Million TWD | 40.186% |
| Great Novel Therapeutics Biotech & Medicals | 2.61 Million TWD | -1486.272% |
| Syngen Biotech Co.,Ltd. | 643.91 Million TWD | 93.558% |
| Anti-Microbial Savior BioteQ Co., Ltd | 329 Thousand TWD | -12508.207% |
| SynCore Biotechnology Co.,Ltd | 46.02 Million TWD | 9.869% |
| Genomics BioSci & Tech. Co.,Ltd. | 119.91 Million TWD | 65.407% |
| Neith Corporation | 66.87 Million TWD | 37.97% |
| Advagene Biopharma Co., Ltd. | 93.33 Million TWD | 55.557% |
| NaviFUS Corp. | 11.82 Million TWD | -250.731% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 190.72 Million TWD | 78.251% |
| Sinew Pharma Inc. | 186.25 Million TWD | 77.729% |
| Andros Pharmaceuticals Co.,Ltd | 74.02 Million TWD | 43.962% |
| Greenyn Biotechnology Co., Ltd | 220.39 Million TWD | 81.179% |
| AP Biosciences Inc | 32.25 Million TWD | -28.611% |
| Medigen Biotechnology Corp. | 1.85 Billion TWD | 97.758% |
| 3D Global Biotech Inc. | 5.27 Million TWD | -686.519% |
| Pharmosa Biopharm Inc. | 317.32 Million TWD | 86.928% |
| Intech Biopharm Corporation | -163.99 Million TWD | 125.294% |
| Oneness Biotech Co., Ltd. | 1.12 Billion TWD | 96.326% |
| Eusol Biotech Co.,Ltd. | 41.48 Million TWD | 0.002% |
| TWi Biotechnology, Inc. | 169.55 Million TWD | 75.536% |
| Ever Supreme Bio Technology Co., Ltd | 147.02 Million TWD | 71.786% |
| TCI GENE Inc. | 174.61 Million TWD | 76.245% |
| MegaPro Biomedical Co., Ltd | 18 Thousand TWD | -230350.0% |
| Senhwa Biosciences, Inc. | 300.93 Million TWD | 86.216% |
| Taiwan Bio Therapeutics Co., Ltd | 290.95 Million TWD | 85.743% |
| NatureWise Biotech & Medicals Corporation | 83.94 Million TWD | 50.586% |
| PharmaEngine, Inc. | 441.78 Million TWD | 90.611% |
| Savior Lifetec Corporation | 223.36 Million TWD | 81.429% |
| TaiGen Biopharmaceuticals Holdings Limited | 258.77 Million TWD | 83.97% |
| OBI Pharma, Inc. | 2.01 Billion TWD | 97.943% |
| Meribank Biotech Co., Ltd | 138.87 Million TWD | 70.13% |
| Acepodia, Inc. | 452.56 Million TWD | 90.834% |
| Caliway Biopharmaceuticals Co., Ltd. | 540.93 Million TWD | 92.332% |